Agrylin

This page contains recent news articles, when available, and an overview of Agrylin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Determination That ATROVENT (Ipatropium Bromide) Inhalation ... - Oct 1, 2008
112 Crescent 4-90 mCi/mL) Injection Ave., Peoria, IL 61606 NDA 20-333 AGRYLIN (anagrelide Shire US Inc., 725 hydrochloride (HCl)) Chesterbrook Blvd., Trading Markets (press release),

FDA Safety Changes: Viramune, Agrylin, Keflex, Furadantin, Mycobutin Sep 11, 2008
On June 17, the FDA approved safety labeling revisions for anagrelide HCl capsules (Agrylin; Shire Pharmaceuticals Corp) to warn of the risk forMedscape (subscription)

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.